Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 31, 2024Biomedical Research and TherapyOpen Access

Immunophenotypic Expression and its Association with Prognostic Factors, Clinical Stages, and Clinical Profiles in Newly Diagnosed Patients with Plasma Cell Myeloma: Insights from Two Tertiary Care Centers

View Full Paper
Ask AI
Bookmark
Share

Authors

NINor Hayati IsmailLPLing PeiNYNik Rus Mazeni Nik Yusoff

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ismail et al. (2024) studied this question.

synapsesocial.com/papers/68e718f5b6db6435876928e7https://doi.org/10.15419/bmrat.v11i3.870
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Circulating tumor plasma cells as an independent prognostic marker in newly diagnosed multiple myeloma: Clinical correlation and immunophenotypic insights2025
  2. 2Phenotypic evolution of circulating plasma cells from early precursor stages to multiple myeloma2026
  3. 3Phenotypic evolution of circulating tumor plasma cells across MGUS, SMM and multiple myeloma2025
  4. 4Surface protein-focused gene expression analysis identifies prognostic immunophenotypes in newly diagnosed multiple myeloma2025
  5. 5The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 study2026